{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T21:47:41Z","timestamp":1789163261354,"version":"build-2803163510"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Adjuvants have been indispensable in vaccinology, enhancing immunogenicity, shaping adaptive immune polarization, and extending the durability of protective responses. Classical adjuvants, including alum, oil-in-water emulsions, liposomal formulations, and toll-like receptor agonists, function by fueling innate immunity, promoting antigen presentation, and modulating cytokine milieus. Yet, these compounds face persistent limitations such as reactogenicity, species-specific responses, manufacturing complexity, and regulatory barriers. Artificial intelligence (AI) and core subfields such as machine learning are revolutionizing vaccine design by enhancing antigen engineering, delivery system optimization, immunogenicity modeling, and\n                    <jats:italic>in silico<\/jats:italic>\n                    screening of novel immune potentiators. Here, I propose a speculative yet testable hypothesis: AI-driven design of potent antigens may progressively replace classical adjuvants. By embedding adjuvant-like functions directly into computationally designed antigens, AI-designed vaccines could replicate or excel the mechanistic roles of traditional adjuvants. This perspective critically explores current AI applications in vaccinology, discusses key challenges in the field, including biological complexity, data limitations, safety, and regulatory and ethical considerations, and outline the spectrum of adjuvant replacement\u2014from augmentation to full substitution. Finally, a roadmap is proposed for transitioning toward AI-driven adjuvant surrogates. Notably, this work highlights a potential paradigm shift in vaccine design, suggesting that future advances will lead to a gradual, stepwise transition from the use of traditional adjuvants to computationally guided antigens and delivery platforms capable of outperforming classical adjuvant functions, thus creating a new vaccine era without exogenous chemical additives.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1710109","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T06:44:39Z","timestamp":1769582679000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Could artificial intelligence gradually replace classical adjuvants?"],"prefix":"10.3389","volume":"17","author":[{"given":"Jose G.","family":"Marchan-Alvarez","sequence":"first","affiliation":[{"name":"Department of Women\u2019s and Children\u2019s Health, Karolinska Institutet","place":["Stockholm, Sweden"]},{"name":"Astrid Lindgren Children\u2019s Hospital","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2510","article-title":"Towards an understanding of the adjuvant action of aluminium","volume":"9","author":"Marrack","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nature06939","article-title":"Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants","volume":"453","author":"Eisenbarth","year":"2008","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20071087","article-title":"Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells","volume":"205","author":"Kool","year":"2008","journal-title":"J Exp Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nri2215","article-title":"How dying cells alert the immune system to danger","volume":"8","author":"Kono","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(89)90011-7","article-title":"Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles: The role of endogenous interleukin 1 in proliferative responses","volume":"121","author":"Grun","year":"1989","journal-title":"Cell Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41541-019-0132-6","article-title":"The how\u2019s and what\u2019s of vaccine reactogenicity","volume":"4","author":"Herv\u00e9","year":"2019","journal-title":"NPJ Vaccines"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2023.03.002","article-title":"Leveraging deep learning to improve vaccine design","volume":"44","author":"Hederman","year":"2023","journal-title":"Trends Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41541-023-00795-8","article-title":"Development and use of machine learning algorithms in vaccine target selection","volume":"9","author":"Bravi","year":"2024","journal-title":"NPJ Vaccines"},{"key":"B9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41541-025-01258-y","article-title":"AI-driven epitope prediction: a system review, comparative analysis, and practical guide for vaccine development","volume":"10","author":"Villanueva-Flores","year":"2025","journal-title":"NPJ Vaccines"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1790\u20139","DOI":"10.1038\/s41587-024-02490-y","article-title":"Artificial intelligence-guided design of lipid nanoparticles for pulmonary gene therapy","volume":"43","author":"Witten","year":"2024","journal-title":"Nat Biotechnol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran B","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"B12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41541-021-00391-8","article-title":"Exploiting viral sensing mediated by Toll-like receptors to design innovative vaccines","volume":"6","author":"Sartorius","year":"2021","journal-title":"NPJ Vaccines"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.8.5402","article-title":"The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells","volume":"180","author":"Seubert","year":"2008","journal-title":"J Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185843","article-title":"Vaccine adjuvant MF59 promotes the intranodal differentiation of antigen-loaded and activated monocyte-derived dendritic cells","volume":"12","author":"Cioncada","year":"2017","journal-title":"PLoS One"},{"key":"B16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1006\/cimm.1998.1283","article-title":"Dendritic cells internalize vaccine adjuvant after intramuscular injection","volume":"186","author":"Dupuis","year":"1998","journal-title":"Cell Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"10316","DOI":"10.1038\/s41467-024-54734-9","article-title":"Machine learning-enhanced immunopeptidomics applied to T-cell epitope discovery for COVID-19 vaccines","volume":"15","author":"Kovalchik","year":"2024","journal-title":"Nat Commun"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1021\/acsmeasuresciau.3c00060","article-title":"Recent developments in machine learning for mass spectrometry","volume":"4","author":"Beck","year":"2024","journal-title":"ACS Measurement Sci Au"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.3c01877","article-title":"A liquid chromatography high-resolution tandem mass spectrometry method to quantify QS-21 adjuvant and its degradation products in liposomal drug formulations","volume":"8","author":"Abucayon","year":"2023","journal-title":"ACS Omega"},{"key":"B20","doi-asserted-by":"publisher","first-page":"105105","DOI":"10.1016\/j.jprot.2024.105105","article-title":"Development of Mass Spectrometry Imaging on skeletal muscle to characterize the local pro-inflammatory and pro-resolution lipid responses in a vaccination context","volume":"296","author":"Ribette","year":"2024","journal-title":"J Proteomics"},{"key":"B21","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12859-021-04155-y","article-title":"DeepNetBim: deep learning model for predicting HLA-epitope interactions based on network analysis by harnessing binding and immunogenicity information","volume":"22","author":"Yang","year":"2021","journal-title":"BMC Bioinf"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.2c00130","article-title":"Immunoinformatics-aided design and in vivo validation of a peptide-based multiepitope vaccine targeting canine circovirus","volume":"5","author":"Kaushik","year":"2022","journal-title":"ACS Pharmacol Transl Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/database\/baz076","article-title":"PRRDB 2.0: a comprehensive database of pattern-recognition receptors and their ligands","volume":"2019","author":"Kaur","year":"2019","journal-title":"Database"},{"key":"B24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1745-6150-8-30","article-title":"Designing of interferon-gamma inducing MHC class-II binders","volume":"8","author":"Dhanda","year":"2013","journal-title":"Biol Direct"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-005-4528-2","article-title":"Modeling the MHC class I pathway by combining predictions of proteasomal cleavage, TAP transport and MHC class I binding","volume":"62","author":"Tenzer","year":"2005","journal-title":"CMLS Cell Mol Life Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.4.1741","article-title":"Identifying MHC class I epitopes by predicting the TAP transport efficiency of epitope precursors","volume":"171","author":"Peters","year":"2003","journal-title":"J Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jctc.3c00513","article-title":"Computational methods in immunology and vaccinology: design and development of antibodies and immunogens","volume":"19","author":"Guarra","year":"2023","journal-title":"J Chem Theory Comput"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.3390\/v16091404","article-title":"mRNA vaccination: an outlook on innate sensing and adaptive immune responses","volume":"16","author":"Shoja Doost","year":"2024","journal-title":"Viruses"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-024-02240-7","article-title":"Can AlphaFold\u2019s breakthrough in protein structure help decode the fundamental principles of adaptive cellular immunity","volume":"21","author":"McMaster","year":"2024","journal-title":"Nat Methods"},{"key":"B30","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-08615-w","article-title":"Cell-autonomous innate immunity by proteasome-derived defence peptides","volume":"639","author":"Goldberg","year":"2025","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1134\/S199074782570031X","article-title":"Prediction of the interaction between NK cell receptor KIR2DS4 and HLA-C*05-peptide complex","volume":"19","author":"Ustiuzhanina","year":"2025","journal-title":"Biochem (Mosc) Suppl Ser A Membr Cell Biol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.5787116","article-title":"AlphaFold 3-guided structural modeling for clinically relevant peptide-HLA class I interactions in SARS-CoV-2 immunity","author":"Marchan-Alvarez","year":"2025"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.5c09066","article-title":"TuNa-AI: A hybrid kernel machine to design tunable nanoparticles for drug delivery","volume":"19","author":"Zhang","year":"2025","journal-title":"ACS Nano"},{"key":"B35","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41577-024-01091-9","article-title":"Vax-Innate: improving therapeutic cancer vaccines by modulating T cells and the tumour microenvironment","volume":"25","author":"Baharom","year":"2025","journal-title":"Nat Rev Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009862","article-title":"Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system","volume":"5","author":"Rapin","year":"2010","journal-title":"PLoS One"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073957","article-title":"In silico approach for predicting toxicity of peptides and proteins","volume":"8","author":"Gupta","year":"2013","journal-title":"PLoS One"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-025-02951-5","article-title":"The virtual cell","volume":"22","author":"Tang","year":"2025","journal-title":"Nat Methods"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-025-01101-y","article-title":"Grow AI virtual cells: three data pillars and closed-loop learning","volume":"35","author":"Qian","year":"2025","journal-title":"Cell Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-016-1111-6","article-title":"Adjuvant effects of a sequence-engineered mRNA vaccine: translational profiling demonstrates similar human and murine innate response","volume":"15","author":"Edwards","year":"2017","journal-title":"J Transl Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1038\/s41598-021-85709-1","article-title":"Site-specific antigen-adjuvant conjugation using cell-free protein synthesis enhances antigen presentation and CD8+ T-cell response","volume":"11","author":"Weiss","year":"2021","journal-title":"Sci Rep"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.4c00925","article-title":"A polymer-based antigen carrier activates two innate immune pathways for adjuvant-free subunit vaccines","volume":"18","author":"Chen","year":"2024","journal-title":"ACS Nano"},{"key":"B43","doi-asserted-by":"publisher","first-page":"120597","DOI":"10.1016\/j.biomaterials.2020.120597","article-title":"Polymeric nanoparticle vaccines to combat emerging and pandemic threats","volume":"268","author":"Wibowo","year":"2021","journal-title":"Biomaterials"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.125107","article-title":"The STING ligand cGAMP potentiates the efficacy of vaccine-induced CD8+ T cells","volume":"4","author":"Gutjahr","year":"2019","journal-title":"JCI Insight"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/imcb.70049","article-title":"Adsorption of antigen to polymeric nanoparticles enhances cytotoxic T-cell responses and anti-tumor immunity by targeting conventional type 1 dendritic cells","volume":"103","author":"Huete-Carrasco","year":"2025","journal-title":"Immunol Cell Biol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1438030","article-title":"Revolutionizing adjuvant development: harnessing AI for next-generation cancer vaccines","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1654807","article-title":"Combining immunoprofiling with machine learning to assess the effects of adjuvant formulation on human vaccine-induced immunity","volume":"16","author":"Chaudhury","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"B48","doi-asserted-by":"publisher","first-page":"100996","DOI":"10.1016\/j.jpha.2024.100996","article-title":"Machine learning-driven optimization of mRNA-lipid nanoparticle vaccine quality with XGBoost\/Bayesian method and ensemble model approaches","volume":"14","author":"Maharjan","year":"2024","journal-title":"J Pharm Anal"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.2196\/76634","article-title":"Ethical implications of artificial intelligence in vaccine equity: protocol for exploring vaccine distribution planning and scheduling in pandemics in low- and middle-income countries","volume":"14","author":"Akuma","year":"2025","journal-title":"JMIR Res Protoc"},{"key":"B50","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s43856-025-00910-x","article-title":"Regulating the AI-enabled ecosystem for human therapeutics","volume":"5","author":"Singh","year":"2025","journal-title":"Commun Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1567116","article-title":"Artificial intelligence in vaccine research and development: an umbrella review","volume":"16","author":"El Arab","year":"2025","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s41467-019-13983-9","article-title":"Integrative pathway enrichment analysis of multivariate omics data","volume":"11","author":"Paczkowska","year":"2020","journal-title":"Nat Commun"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.5c00245","article-title":"Critical assessment of RNA and DNA structure predictions via artificial intelligence: the imitation game","volume":"65","author":"Bergonzo","year":"2025","journal-title":"J Chem Inf Model"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/prot.26237","article-title":"Critical assessment of methods of protein structure prediction (CASP)\u2014Round XIV","volume":"89","author":"Kryshtafovych","year":"2021","journal-title":"Proteins: Structure Function Bioinf"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1710109\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T06:44:40Z","timestamp":1769582680000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1710109\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":54,"alternative-id":["10.3389\/fimmu.2026.1710109"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1710109","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"article-number":"1710109"}}